Upward Trend in Chronic Disease Occurrence
In the BRICS countries — Brazil, Russia, India, China, and South Africa — healthcare systems are confronting a noticeable rise in chronic health conditions that drive demand for advanced interventional treatments. Cardiac disorders, particularly arrhythmias that are challenging to manage with medications alone, are becoming more commonly treated in specialized centers. Cryoablation is gaining interest as a minimally invasive option that complements existing electrophysiology procedures in leading hospitals across these markets.
In Brazil, major cardiology institutes in São Paulo and Rio de Janeiro are increasingly performing ablation procedures as part of comprehensive cardiac care programs, reflecting a shift in clinical practice toward less invasive interventions. Similarly, in Russia and China, urban cardiology departments are expanding their procedural portfolios to include advanced ablation tools to meet the needs of aging populations experiencing more complex forms of heart disease. In India and South Africa, private tertiary care facilities are also introducing cryoablation alongside conventional therapies to serve patients seeking reduced downtime after treatment.
Chronic conditions beyond cardiac disease are also shaping demand. Oncology teams in BRICS nations are exploring focal therapies that allow for the treatment of select tumors without extensive surgery, aligning with the broader trend of adopting minimally invasive approaches. As chronic illnesses become more prevalent across BRICS healthcare landscapes, clinicians and hospital administrators are increasingly recognizing cryoablation as a strategic addition to procedural offerings that can address evolving patient needs.
Pursuing Additional Clinical Opportunities
While cryoablation’s initial adoption in BRICS has focused predominantly on cardiac arrhythmia management, clinical interest is broadening into other therapeutic areas. In China and India, interventional radiologists and oncology specialists are evaluating cryoablation for soft-tissue and organ-specific applications, particularly for patients who are not ideal candidates for standard surgical resection. This reflects an overall willingness among clinicians to explore the technology’s utility beyond its traditional niche.
Oncology units in Brazil and South Africa are incorporating cryoablation into multidisciplinary care strategies for localized tumors, using image-guided approaches to target diseased tissue with precision. These efforts allow clinicians to offer additional options for patients seeking less invasive treatments with potentially shorter recovery times. In several metropolitan treatment centers, cryoablation is now part of case discussions alongside other ablation modalities and interventional therapies.
Emerging uses in pain management and palliative care are also gaining traction in BRICS markets. Clinicians are experimenting with cryoablation for nerve-related pain conditions, leveraging its ability to target specific anatomic areas with minimal collateral injury. While these indications are still in development compared with cardiac and oncology applications, they show the expanding interest in using cryoablation across a wider range of clinical scenarios. As procedural expertise and technology access grow across BRICS healthcare systems, the market is expected to embrace these broader clinical opportunities.
